ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $120,903,000 | -12.8% | 10,272,054 | +1.1% | 0.03% | -12.9% |
Q1 2019 | $138,672,000 | +183.9% | 10,159,082 | +113.2% | 0.03% | +158.3% |
Q4 2018 | $48,843,000 | -29.1% | 4,765,123 | +15.1% | 0.01% | -20.0% |
Q3 2018 | $68,934,000 | -11.0% | 4,140,169 | -15.5% | 0.02% | -11.8% |
Q2 2018 | $77,420,000 | +22.2% | 4,899,955 | -1.8% | 0.02% | +21.4% |
Q1 2018 | $63,354,000 | +22.5% | 4,988,478 | +10.5% | 0.01% | +27.3% |
Q4 2017 | $51,697,000 | -14.1% | 4,515,093 | -8.1% | 0.01% | -21.4% |
Q3 2017 | $60,183,000 | +46.1% | 4,912,870 | +36.6% | 0.01% | +40.0% |
Q2 2017 | $41,188,000 | -45.6% | 3,597,231 | -1.2% | 0.01% | -44.4% |
Q1 2017 | $75,728,000 | +0.7% | 3,640,788 | +0.7% | 0.02% | -5.3% |
Q4 2016 | $75,170,000 | -40.2% | 3,613,997 | -5.8% | 0.02% | -38.7% |
Q3 2016 | $125,714,000 | +14.9% | 3,836,272 | -12.4% | 0.03% | +10.7% |
Q2 2016 | $109,367,000 | +41.5% | 4,379,963 | +38.7% | 0.03% | +40.0% |
Q1 2016 | $77,310,000 | +72.9% | 3,156,865 | +133.2% | 0.02% | +66.7% |
Q4 2015 | $44,715,000 | +3350.2% | 1,353,755 | +3323.0% | 0.01% | – |
Q3 2015 | $1,296,000 | -45.8% | 39,549 | -12.4% | 0.00% | -100.0% |
Q2 2015 | $2,393,000 | -63.7% | 45,169 | -80.2% | 0.00% | -50.0% |
Q1 2015 | $6,585,000 | -26.5% | 228,169 | -26.0% | 0.00% | 0.0% |
Q4 2014 | $8,965,000 | +191.6% | 308,189 | +27.1% | 0.00% | +100.0% |
Q3 2014 | $3,074,000 | -1.1% | 242,419 | +56.5% | 0.00% | 0.0% |
Q2 2014 | $3,109,000 | – | 154,919 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 229,895 | $7,593,000 | 6.73% |
Foresite Capital Management II, LLC | 419,997 | $13,873,000 | 4.65% |
Cormorant Asset Management, LP | 757,475 | $25,019,000 | 2.99% |
NEXTHERA CAPITAL LP | 60,000 | $1,982,000 | 2.81% |
SENZAR ASSET MANAGEMENT, LLC | 557,170 | $18,403,325,000 | 2.05% |
Parametrica Management Ltd | 9,360 | $309,000 | 2.04% |
Partner Investment Management, L.P. | 36,756 | $1,214,000 | 1.99% |
PFM Health Sciences, LP | 1,890,030 | $62,428,000 | 1.90% |
PYRRHO CAPITAL MANAGEMENT, LP | 63,000 | $2,081,000 | 1.40% |
BB BIOTECH AG | 1,510,150 | $49,880,000 | 1.40% |